David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 20,000 shares at $23.79 ($459K) on 2015-06-16, disclosed to the SEC on 2015-06-19.
Scheduled sale ($459k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.82 | 17,200 | $393K | 85.5% |
| 2 | $23.79 | 2,800 | $67K | 14.5% |
| Total | $22.96 avg | 20,000 | $459K | 100% |
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |